CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alcon Pharmaceuticals Ltd. v. Akorn, Inc.

1:15-cv-00948

Overview

Case Number 1:15-cv-00948
Filing Date 2015-10-21
Status Terminated
Termination Date 2015-11-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Akorn, Inc. Operating Company

Represented By

1 Attorneys Listed

Shanti Mulpuru Katona

Polsinelli PC

Tel: +1 (302) 252-0924

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Plaintiff

Alcon Research, Ltd. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Alcon Pharmaceuticals Ltd. Operating Company

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (8 found):
PTAB: 2 U.S. Courts: 6
USPTO PTAB Trial 2012-10-12
IPR2013-00015

Apotex Inc. v. Alcon

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2012-10-05
IPR2013-00012

Apotex Inc. v. Alcon Pharmaceuticals Ltd.

U.S. Continuation Sibling (6716830)
Status: Terminated-Settled
U.S. District Court 2016-06-30
1:16-cv-00563

Alcon Pharmaceuticals Ltd. v. Imprimis Pharmaceuticals, Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-10-24
1:14-cv-00970

Wavetronix LLC v. Iteris, Inc.

Asserted Patent
Status: TXWD
U.S. District Court 2014-07-15
1:14-cv-00930

Alcon Pharmaceuticals Ltd v. Aurobindo Pharma Ltd.

Asserted Patent
Status: DED
U.S. District Court 2012-07-24
1:12-cv-00973

Alcon Pharmaceuticals Ltd v. Lupin Ltd.

Asserted Patent
Status: DED
U.S. District Court 2012-07-20
1:12-cv-00960

Alcon Pharmaceuticals Ltd v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2011-04-07
1:11-cv-00293

Alcon Pharmaceuticals Ltd v. Watson Laboratories Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6716830
Ophthalmic antibiotic compositions containing moxifloxacin
Filed: 2002-07-22
Issued: 2004-04-06
Expired (Term Ended)
Expires: 2022-07-22
US7671070
Method of treating ophthalmic infections with moxifloxacin compositions
Filed: 2003-11-17
Issued: 2010-03-02
Expired (Term Ended)
Expires: 2023-11-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(15 total)
Pleading / Complaint

COMPLAINT filed against Akorn, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1812471.) - filed by Alcon Research, Ltd., Alcon Pharmaceuticals Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sec) (Entered: 10/21/2015)

Entry #1 • 2015-10-21
1
Pleading / Complaint

COMPLAINT filed against Akorn, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1812471.) - filed by Alcon Research, Ltd., Alcon Pharmaceuticals Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sec) (Entered: 10/21/2015)

Entry #1 • 2015-10-21
2
Pleading / Complaint

COMPLAINT filed against Akorn, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1812471.) - filed by Alcon Research, Ltd., Alcon Pharmaceuticals Ltd.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(sec) (Entered: 10/21/2015)

Entry #1 • 2015-10-21
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 10/21/2015)

Entry #2 • 2015-10-21
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/28/2015. Date of Expiration of Patent: 3/29/2020.Thirty Month Stay Deadline: 3/28/2018. (sec) (Entered: 10/21/2015)

Entry #3 • 2015-10-21
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc